Joerg Gruber

SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ

Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY.

Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker.

DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions.

Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland.

Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation.